Arch Therapeutics, Inc. (ARTHQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Apr 25, 2025
Arch Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2014 - 2018 |
Cash & Equivalents | 0.03 | 0.22 | 0.75 | 2.27 | 0.96 | 2.18 | Upgrade
|
Cash & Short-Term Investments | 0.03 | 0.22 | 0.75 | 2.27 | 0.96 | 2.18 | Upgrade
|
Cash Growth | -65.30% | -70.18% | -67.05% | 136.28% | -56.00% | -53.29% | Upgrade
|
Inventory | 1.32 | 1.36 | 1.41 | 1.09 | 0.97 | 0.35 | Upgrade
|
Prepaid Expenses | 0.04 | 0.36 | 0.44 | 0.31 | 0.18 | 0.36 | Upgrade
|
Other Current Assets | - | - | - | - | 0.04 | - | Upgrade
|
Total Current Assets | 1.39 | 1.95 | 2.6 | 3.67 | 2.14 | 2.89 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0 | 0.01 | 0 | 0.01 | Upgrade
|
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Assets | 1.4 | 1.96 | 2.6 | 3.68 | 2.15 | 2.9 | Upgrade
|
Accounts Payable | 2.92 | 2.3 | 1.33 | 0.41 | 0.34 | 0.53 | Upgrade
|
Accrued Expenses | 1.65 | 1.53 | 0.69 | 0.32 | 0.21 | 0.18 | Upgrade
|
Current Portion of Long-Term Debt | 9.39 | 5.63 | 0.55 | - | 0.04 | - | Upgrade
|
Current Portion of Leases | - | - | - | - | 0.04 | - | Upgrade
|
Other Current Liabilities | - | - | 0.75 | 1 | - | - | Upgrade
|
Total Current Liabilities | 13.96 | 9.47 | 3.32 | 1.73 | 0.63 | 0.71 | Upgrade
|
Long-Term Debt | - | - | 2.81 | 1.6 | 0.69 | - | Upgrade
|
Other Long-Term Liabilities | - | - | 0.66 | 1.37 | 2.33 | 3 | Upgrade
|
Total Liabilities | 13.96 | 9.47 | 6.8 | 4.7 | 3.65 | 3.71 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0.24 | 0.19 | 0.17 | Upgrade
|
Additional Paid-In Capital | 60.03 | 54.54 | 50.88 | 48.53 | 41.86 | 37.89 | Upgrade
|
Retained Earnings | -72.59 | -62.06 | -55.07 | -49.8 | -43.56 | -38.87 | Upgrade
|
Shareholders' Equity | -12.56 | -7.51 | -4.19 | -1.03 | -1.5 | -0.81 | Upgrade
|
Total Liabilities & Equity | 1.4 | 1.96 | 2.6 | 3.68 | 2.15 | 2.9 | Upgrade
|
Total Debt | 9.39 | 5.63 | 3.36 | 1.6 | 0.77 | - | Upgrade
|
Net Cash (Debt) | -9.36 | -5.41 | -2.62 | 0.67 | 0.19 | 2.18 | Upgrade
|
Net Cash Growth | - | - | - | 243.61% | -91.10% | -53.29% | Upgrade
|
Net Cash Per Share | -1.69 | -1.76 | -2.18 | 0.61 | 0.21 | 2.62 | Upgrade
|
Filing Date Shares Outstanding | 4.44 | 4.74 | 1.25 | 1.18 | 0.97 | 0.93 | Upgrade
|
Total Common Shares Outstanding | 4.44 | 4.69 | 1.25 | 1.18 | 0.97 | 0.86 | Upgrade
|
Working Capital | -12.57 | -7.52 | -0.72 | 1.94 | 1.51 | 2.18 | Upgrade
|
Book Value Per Share | -2.83 | -1.60 | -3.36 | -0.87 | -1.55 | -0.94 | Upgrade
|
Tangible Book Value | -12.56 | -7.51 | -4.19 | -1.03 | -1.5 | -0.81 | Upgrade
|
Tangible Book Value Per Share | -2.83 | -1.60 | -3.36 | -0.87 | -1.55 | -0.94 | Upgrade
|
Machinery | - | - | - | 0.02 | 0.02 | 0.02 | Upgrade
|
Leasehold Improvements | - | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.